glp-1 drugs and anxiety The risk of depression, anxiety, suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy GLP-1 Medications: A Game Changer
Description
95 Short-acting GLP-1RAs are generally less studied in MASLD
Diabetes 2023, 73, 3850
I think knowing that going in, while understanding the current side effects of GLP-1s, is your best tool for making a decision about the medication. Published August 2025
GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice
The use of metformin in women with polycystic ovary syndrome: an updated review
